In a recent study presented at the American Academy of Dermatology’s annual meeting, researchers examined the efficacy of various doses of an oral JAK1/JAK2 inhibitor for treating patients with...
In a post-hoc analysis of the ALLEGRO phase 2b/3 trial, researchers evaluated whether scalp, eyebrow, and eyelash hair regrowth would continue over 48 weeks in patients with alopecia areata treated with...
In a recent study presented at the American Academy of Dermatology’s 2023 annual meeting, researchers examined the relationship between scalp hair loss severity and baseline distribution of eyebrow and...
Alopecia can have a significant negative impact on a patient’s quality of life, so it is important to understand its clinical features. This article summarizes a presentation on alopecia by Britt Craiglow,...
